HOXA10 expression in endometrial adenocarcinoma

Tumor Biology

Volumn 25, Issue 5-6, 2004, Pages 264-269

  Lane, Danielle B ^a   Rutherford, Thomas J ^a   Taylor, Hugh S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endometrial adenocarcinoma; Estrogen receptor; Homeobox genes; p53; Progesterone receptor

Indexed keywords

ESTROGEN RECEPTOR; HOMEODOMAIN PROTEIN; PROGESTERONE RECEPTOR; PROTEIN P53;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITOMETRY; ENDOMETRIUM; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA EXTRACTION; STATISTICAL SIGNIFICANCE; UTERUS;

EID: 11444263380     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081390     Document Type: Article

References (26)

1. DiSaia PJ, Creasman WT: Adenocarcinoma of the uterus; in DiSaia PJ, Creasman WT (eds): Clinical Gynecologic Oncology. St Louis, Mosby, 1997, pp 134-167.
2. National Cancer Institute: SEER Cancer Statistics Review, 1973-1998.
3. Jemal A, Thomas A, Murray T, Thun M: Cancer statistics, 2002. Cancer J Clin 2002;52:23-47.
4. Mikutta JJ: International Federation of Gynecology and Obstetrics Staging of Endometrial Cancer. Cancer 1993;71:1460-1463.
5. Rose PG: Endometrial Carcinoma. New Engl J Med 1996;335:640-649.
6. Koul A, Willen R, Bendahl PO, Nilbert M, Borg A: Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis. Cancer 2002;94:2369-2379.
7. Salvesen HB, Iverson OE, Akslen LA: Prognostic impact of morphometric nuclear grade of endometrial carcinoma. Cancer 1998;83:956-964.
8. Salvesen HB, Stefansson I, Kalvenes MD, Das S, Akslen LA: Loss of PTEN expression is associated with metatastic disease in patients with endometrial carcinoma. Cancer 2002;94:2185-2191.
9. Hachisuga T, Kawarbayashi T, Iwasaka T, Sugimori H, Kamura T, Tsuneyoshi M: The prognostic value of semiquantitative nuclear grading in endometrial carcinomas. Gynecol Oncol 1997;65:115-120.
10. FIGO Stages, 1988 Revision. Gynecol Oncol 1989;35:125.
11. McGinnis W, Krumlauf R: Homeobox genes and axial patterning. Cell 1992;68:283-302.
12. Taylor HS: The role of HOX genes in human implantation. Hum Reprod Update 2000;6:75-79.
13. Taylor HS, Vandenheuvel GB, Igarashi P: A conserved Hox axis in the mouse and human female reproductive system - late establishment and persistent adult expression of the hoxa cluster genes. Biol Reprod 1997;57:1338-1345.
14. Taylor HS, Arici A, Olive D, Igarashi P: HOXA10 is expressed in response to sex steroids at the time of implantation in the human endometrium. J Clin Invest 1998;101:1379-1384.
15. Kurman RJ: Endometrial Carcinoma; in Kurman RJ (ed): Blaustein's Pathology of the Female Genital Tract. New York, Springer, 1994, pp 439-486.
16. Chu MC, Taylor HS: HOXA10 is expressed in human breast cancer cell lines and regulates p53 expression. J Soc Gynecol Invest 2002;8:131A.
17. Cass I, Baldwin RL, Fasylova E, Fields AL, Klinger HP, Runowicz CD, Karlan BY: Allelotype of papillary serous peritoneal carcinomas. Gynecol Oncol 2001;82:69-76.
18. Carcangiu ML, Chambers JT: Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: Comparison of clinicopathologic features and survival. Int J Gynecol Pathol 1995;14:30-38.
19. Carcangiu ML, Tan LK, Chambers JT: Stage IA uterine serous carcinoma: A study of 13 cases. Am J Surg Pathol 1997;21:1507-1514.
20. Price FV, Chambers SK, Carcangiu ML, Schwartz PE, Chambers JT: CA 125 may not reflect disease status in patients with uterine serous carcinoma. Cancer 1998;82:1720-1725.
21. Lawrence HJ, Sauvageau G, Ahmadi N, Lopez AR, LeBeau MM, Link M, Humphries K, Largman C: Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells. Exp Hematol 1995;23:1160-1166.
22. Wang CB, Wang CJ, Huang HJ, Hsueh S, Chou HH, Soong YK, Lai CH: Fertility-preserving treatment in young patients with endometrial adenocarcinoma. Cancer 2002;94:2192-2198.
23. Osborne JL, Changzi H, Hawley C, Underwood LJ, O'Brien TJ, Baker VV: Expression of HOXD10 gene in normal endometrium and endometrial adenocarcinoma. J Soc Gynecol Invest 1998;5:277-280.
24. Akbas GE, Taylor HS: HOXC and HOXD gene expression in human endometrium: Lack of redundancy with HOXA paralogs. Biol Reprod 2004;70:39-45.
25. Kounelis S, Kapranos N, Kouri E, Coppola D, Papadaki H, Jones MW: Immunohistochemical profile of endometrial adenocarcinoma: A study of 61 cases and review of the literature. Mod Pathol 2000;13:379-388.
26. Niwa K, Murase T, Morishita S, Hashimoto M, Itoh N, Tamaya T: p53 overexpression and mutation in endometrial carcinoma: Inverted relations with estrogen and progesterone receptor status. Cancer Detect Prev 1999;23:147-154.